FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/10/021480 [Registered on: 01/10/2019] Trial Registered Prospectively
Last Modified On: 10/12/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical trial to study the effects of two formulations , Mutrakruchchrahara Kwath and Shatavari Gokshura Kwath in patients with Pittaj Mutrakruchra with special reference to urinary tract infection. 
Scientific Title of Study   Randomized open controlled clinical study to assess the effect of Mutrakruchchrahara kwath in Pittaj Mutrakruchra with special reference to urinary tract infection. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sharang Arun Shirke 
Designation  PG Scholar 
Affiliation  Yashwant Ayurved College Postgraduate Training and Research Centre,Kodoli 
Address  Department of Kayachikitsa, Yashwant Ayurved College and PG training and research center, Kodoli

Kolhapur
MAHARASHTRA
416112
India 
Phone  9168769133  
Fax    
Email  sharang.shirke@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vd Suryakiran P Wagh 
Designation  HOD 
Affiliation  Yashwant Ayurved College Postgraduate Training and Research Centre,Kodoli 
Address  Department of Kayachikitsa, Yashwant Ayurved College and PG training and research center, Kodoli

Kolhapur
MAHARASHTRA
416114
India 
Phone  9822846910  
Fax    
Email  suryakiran_wagh@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Sharang Arun Shirke 
Designation  PG Scholar 
Affiliation  Yashwant Ayurved College Postgraduate Training and Research Centre,Kodoli 
Address  Department of Kayachikitsa, Yashwant Ayurved College and PG training and research center, Kodoli

Kolhapur
MAHARASHTRA
416112
India 
Phone  9168769133  
Fax    
Email  sharang.shirke@gmail.com  
 
Source of Monetary or Material Support  
Sharang Arun Shirke 
Yashwant Ayurved College and PG training and research center, Kodoli 
 
Primary Sponsor  
Name  Sharang Arun Shirke 
Address  Kumbhar lano no.1 A/p Vathar Tarf Vadgaon,Kolhapur 
Type of Sponsor  Other [SELF SPONSERED] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
VD SURYAKIRAN P WAGH  Yashwant Ayurved College Postgraduate Training and Research Centre   KODOLI
Kolhapur
MAHARASHTRA 
9822846910

SURYAKIRAN_WAGH@REDIFFMAIL.COM 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
BORS Committee of the College  Approved 
INSTITUTE ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N390||Urinary tract infection, site notspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Gokshura Shatavari Kwath  50 ml of kwath, twice a day, after meals, for 7 days. 
Intervention  Mutrakeuchchrahara Kwath  50 ml of kwath, twice a day, after meals, for 7 days. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient having sign and symptoms of pittaj Mutrakruchchra.
Patients irrespective of gender, economic class, caste, religion.
Urine routine examination - pus cells upto 10hpf.  
 
ExclusionCriteria 
Details  Pregnancy and lactating mother
Patients with malignancy, diabetes mellitus, BPH, pyelonephritis, traumatic cause
UTI associated with calculus which need surgical intervention
Known HIV and HbSAg positive patients 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
NORMALIATION OF PUSS CELL COUNT
REDUCTION OF SYMPTOMS LIKE BURNING MICTURITION , FREQUENCY OF URINATION, HEAMATURIA, PAINFUL MICTURITION.  
7 days 
 
Secondary Outcome  
Outcome  TimePoints 
NORMALIATION OF PUSS CELL COUNT
REDUCTION OF SYMPTOMS LIKE BURNING MICTURITION , FREQUENCY OF URINATION, HEAMATURIA, PAINFUL MICTURITION.  
7 DAYS 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   07/10/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details
Modification(s)  
THE ANTISEPTIC, Volume 117, No 8, August 2020, ISSN 0003-5998, Page No 31  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   THIS STUDY IS RANDOMIZED OPEN CONTROLLED CLINICAL STUDY TO ASSESS THE EFFECT OF MUTRAKRUCHCHRAHARA KWATH, 50 ML TWICE A DAY, AFTER MEAL, WITH LUKE WARM WATER, FOR
DAYS AND GOKSHURA SHATAVARI KWATH, 50 ML, TWICE A DAY, AFTER MEAL, WITH LUKE WARM WATER, FOR 7 DAYS IN PATIENTS OF PITTAJ MUTRAKRUCHRA.

PATIENTS WITH AGE 20 TO 60 YEARS , BOTH GENDERS,WITH  FOLLOWING SYMPTOMS WILL BE RANDOMLY SELECTED FOR TRIAL. 
1) MUTRADAHA I.E.BURNING MICTURITION 
2) MUHURMUHUR MUTRAPRAVRUTTI I.E. FREQUENCY OF MICTURITION. 
3) SARUJA I.E. PAIN WHILE MICTURITION 
4) SARAKTA  MUTRATA I.E. RBC IN URINE EXAMINATION . 
5) URINE EXAMINATION SHOWING PUS CELLS UPTO 10 HPF

STUDY WILL BE CONDUCTED IN SAME INSTITUTE TILL THE SAMPLE SIZE IS COMPLETED. 
PRIMARY OUTCOME WILL BE REDUCTION OF SYMPTOMS RELATED TO URINARY TRACT INFECTION ALSO REDUCTION IN PUS CELLS. 
INTERVENTION DURATION FOR EACH PATIENT WILL BE 7 DAYS. 
PATIENTS URINE WILL BE EXAMINED ON DAY 0 AND DAY 7 . 
CONCLUSION WILL BE DRAWN ON ANALYSIS BASED ON SYMPTOM REDUCTION AND PUS CELLS REDUCTION IN BOTH GROUPS.

 
Close